S&P 500, NASDAQ HOLD NEAR RECORDS; NVIDIA DIPS

Oil gains as ECB lowers rates, Saudi Arabia signals flexibility on output cut phaseout

MRNA Jan 2025 140.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

36.60

+3.10

(+9.25%)

As of 12:12PM EDT. Market open.

Loading interactive chart...

Zacks
5 Stocks Propelling S&P 500 to 25th Record High
The S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO, MU and LRCX, leading the way higher in the latest trading session.
ACCESSWIRE
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address unmet medical needs for rare diseases CAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) ...
Zacks
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.